News
US FDA Names Agency Critic Vinay Prasad as Top Vaccine Official
(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research, the agency said on Tuesday.
Vinay Prasad, Critic of COVID Measures, Picked as FDA's Top Vaccine Official
Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center that oversees vaccine approvals.
Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...
Five years after the onset of the COVID-19 pandemic, 42 percent of people in the U.S. think federal health agencies are ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about the ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
Proposed changes to the vaccine approval system deserve the same scrutiny. Press reports indicate that new vaccines will be ...
On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback